BioOrbit 🇬🇧
BioOrbit is developing a scalable platform for the crystallization of protein drugs in microgravity to enhance manufacturing of complex biologics.
About BioOrbit
BioOrbit is a UK-based company founded in 2023, now around 18 people. It has raised $13.3M in disclosed funding. FundFinder classes it as Health & Bio.
Founded by Katie King, Phd (CEO and Co-Founder; previously Boom Cymru, Frontier Space; International Space University), Leonor Teles (Co-Founder; previously José de Mello Saúde; Utrecht University), Chana Rose Hochman (Co-Founder and COO; previously Elbit Systems Israel, ISI - ImageSat International; Tel Aviv University).
Its investors also appear on FundFinder's most-active lists for Seed · Fintech (111 funds), Seed · Impact (35 funds).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Seed · Apr 2026
Auxxo Female Catalyst Fund GmbH- Auxxo Female Catalyst Fund GmbH — Auxxo Female Catalyst Fund GmbH · cheques £700k – £3M